Search
Contact
31.03.2015 | KPMG Law Insights

Alternative Investments Legal – Alternative Investments Legal | Issue 2/2015

Dear Readers,

After the Investment Ordinance has come into force in the meantime, we are using this newsletter for some more in-depth information.

Furthermore, BaFin has updated the KAGB application letter. With the revision, the supervisory authority is pre-empting a proposal by the German Federal Council on the Small Investor Protection Act and is removing cooperatives from the regulated scope of application. BaFin also revised its FAQ letter on sales. The submission deadline for the AIFMD reporting has been postponed by BaFin to mid-May 2015 at the earliest.

At the European level, ESMA has published its updated FAQs on the AIFM Directive.

In addition, the Bundesrat approved the German implementation law for “Solvency II”.

We hope you enjoy reading this issue and wish you a happy Easter.

With best regards

Dr. Ulrich Keunecke

New investment regulation now in force

The investment regulation now promulgated and which came into force on March 7, 2015, allows, among other things, investment funds that invest 100 percent in unsecuritized loan receivables (debt funds) in the tied assets of insurers. It remains unclear whether such funds regularly fall under the newly introduced blending ratio for alternative investments of 7.5 percent or whether other models are also conceivable.

In the future, investments in open-end and closed-end special real estate investment funds and in closed-end public real estate investment funds, among others, will also be eligible for the real estate quota if structured appropriately. Both German and EU investment assets are eligible as fund vehicles.

Furthermore, “private equity funds” in the form of domestic closed-end public AIFs and special AIFs are now explicitly covered by the Investment Regulation.

BaFin updates letter on KAGB scope of application

On March 9, 2015, BaFin updated the interpretative letter on the scope of application of the KAGB and the concept of investment assets. The scope of application with regard to cooperatives has been amended. In the opinion of BaFin, the mandatory orientation of the cooperative towards a special promotional purpose, as laid down in the Cooperatives Act, precludes a pure profit-making intention that is typical of funds. Accordingly, cooperatives regularly do not pursue a fixed investment strategy, so that there is no investment fund within the meaning of the KAGB.

BaFin has thus moved ahead of the proposal of the Bundesrat in its opinion on the Small Investor Protection Act (cf. Newsletter AIL February 2015).

 

BaFin publishes revised FAQ letter on distribution under KAGB

On March 20, 2015, BaFin published a revision of the letter “Häufige Fragen zum Vertrieb und Erwerb von Investmentvermögen nach dem KAGB”. BaFin clarifies that the term “placing” within the meaning of section 293 para. 1 sentence 1 KAGB includes any active disposal of units or shares of an investment fund. The term placement in the KAGB thus does not correspond to the term placement used in the KWG or WpHG.

BaFin again postpones submission deadline for AIFMD reporting

BaFin has again amended the “Merkblatt zu den Meldepflichten von AIF-Verwaltungsgesellschaften” on March 5, 2015. The initially announced initial submission deadline of March 16, 2015 is no longer applicable. This is justified by technical delays at ESMA. BaFin currently assumes that the first report will be required from around mid-May 2015.

ESMA presents updated FAQ on the AIFM Directive

On March 26, 2015, ESMA published its updated FAQ on the AIFM Directive. Among other things, there are new developments in the areas of reporting and notification requirements as well as in the calculation of leverage. Supplementary questions regarding additional own funds and the scope of application were also answered.

Bundesrat approves law to modernize financial supervision of insurance companies

On March 6, 2015, the Bundesrat approved the Act on the Modernization of Financial Supervision of Insurance Companies. The law is scheduled to enter into force on January 1, 2016. It transposes the 2009 European “Solvency II” Directive into German law.

Among other things, the law requires insurance companies to hold more equity capital as a precaution for times of crisis. It also mandates the implementation of improved risk management. In return, insurers are to be given more flexibility in investing the funds they manage. The current quantitative investment criteria are to be replaced by qualitative capital adequacy requirements.

Updated timeline for AIFMD passporting.

At the end of February 2015, ESMA presented its work program for 2015. With regard to alternative investments, ESMA must publish both an opinion on the functioning of the EU passport and a recommendation on its application to the marketing of third country AIFs or by third country AIFMs by 22 July 2015 at the latest.

Both papers are prerequisites for the adoption of delegated acts to implement the envisaged passport scheme in a binding manner in all member states. The EU passport for all AIFs and AIFMs has so far essentially regulated under which conditions units or shares of an EU AIF may be marketed in EU member states other than the home state of the AIFM and which conditions must be met for an EU AIFM to be allowed to manage an EU AIF domiciled in another member state.

Explore #more

09.01.2025 | In the media

KPMG Law strengthens Legal Transformation Managed Services and Legal Corporate Services with two new senior managers

On January 1, KPMG Law strengthened its Transformation Managed Services practice with Jana Sichelschmidt and its Corporate Services practice with Dr. Michaela Lenk. Both are…

06.01.2025 | Deal Notifications

KPMG Law advises on the sale of Käppler & Pausch GmbH

Gabriel Pausch, the co-founder and main shareholder of Käppler & Pausch GmbH, a system supplier for metal assemblies as well as metal and sheet metal…

03.01.2025 | In the media

Interview in Betrieb on the EU money laundering package and its impact

The EU anti-money laundering package harmonizes anti-money laundering and counter-terrorism rules in Europe and introduces new measures such as cash limits of €10,000, identification requirements…

02.01.2025 | In the media

KPMG Law Statement in eMagazin Immobilienanwälte: Creativity meets law in trademark protection

Four Frankfurt, Elbtower, Vonovia: real estate projects and companies are backed by constructs worth millions or even billions. In order to stand out from the…

20.12.2024 | KPMG Law Insights

The EU packaging regulation sets strict requirements for packaging

The EU has adopted the Packaging Regulation. After the European Parliament adopted the Commission’s draft on April 24, 2024, the EU member states also approved…

20.12.2024 | Deal Notifications

KPMG and KPMG Law supported the sale of circular Informationssysteme to the teccle group

Together with the corporate finance/M&A advisors of KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG), KPMG Law Rechtsanwaltsgesellschaft mbH (KPMG Law) advised the shareholders of circular Informationssysteme GmbH (circular)…

19.12.2024 | Press releases

KPMG Law defends Federal Motor Transport Authority against claim for damages in connection with the emissions scandal

The state is not liable to vehicle purchasers for damages. KPMG Law has defended the Federal Motor Transport Authority (KBA) against a civil plaintiff’s state…

18.12.2024 | KPMG Law Insights, KPMG Law Insights

MiCAR – What the new EU regulation means for crypto service providers and issuers

An EU regulation will soon come into force that will regulate crypto assets uniformly throughout Europe. It contains significant new obligations for issuers and crypto…

16.12.2024 | Deal Notifications

KPMG Law advises CERTANIA Holding GmbH on the acquisition of RASG Holdco Ltd.

KPMG Law Rechtsanwaltsgesellschaft mbH (KPMG Law) has provided legal advice to CERTANIA Holding GmbH, a platform of the Munich-based PE firm Greenpeak Partners, on the…

04.12.2024 | Deal Notifications

KPMG Law and KPMG advises Brain Biotech AG on license agreements and monetization of license rights

KPMG Law Rechtsanwaltsgesellschaft mbH and KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG) advised Brain Biotech AG on the monetization of licensing rights with Royalty Pharma and the conclusion…

Contact

Dr. Ulrich Keunecke

Partner
Leiter Sector Legal FS Insurance

Heidestraße 58
10557 Berlin

Tel.: +49 30 530199 200
ukeunecke@kpmg-law.com

© 2024 KPMG Law Rechtsanwaltsgesellschaft mbH, associated with KPMG AG Wirtschaftsprüfungsgesellschaft, a public limited company under German law and a member of the global KPMG organisation of independent member firms affiliated with KPMG International Limited, a Private English Company Limited by Guarantee. All rights reserved. For more details on the structure of KPMG’s global organisation, please visit https://home.kpmg/governance.

 KPMG International does not provide services to clients. No member firm is authorised to bind or contract KPMG International or any other member firm to any third party, just as KPMG International is not authorised to bind or contract any other member firm.

Scroll